UROLOGY
Leverage our clinical expertise to help you tackle the development needs of your urology compound. Having conducted almost 13 studies, we are skilled in general toxicology, safety pharmacology, and clinical pharmacology of a wide range of compounds. Our experience covers treatments for urinary incontinence, erectile dysfunction, benign prostate hyperplasia, and prostate cancer. We can also analyze a number of different biomarkers. With our extensive patient database and outreach, we can help you establish proof of concept by recruiting patients across a range of urological conditions.
Urology trials are clinical trials conducted to investigate new treatments, interventions, or therapies related to urological disorders. These trials play a crucial role in advancing the understanding of conditions affecting the urinary tract and male reproductive system, improving treatment options, and enhancing patient care.
Types of Urology Trials:
- Drug Trials: Investigate the safety and efficacy of new medications for various urological disorders, including urinary tract infections, kidney stones, prostate conditions, and bladder cancers.
- Surgical Trials: Evaluate new surgical techniques, procedures, or interventions for conditions such as prostate cancer, kidney tumors, and urinary incontinence.
- Device Trials: Assess the effectiveness and safety of medical devices used in urology, including stents, catheters, and imaging technologies.
- Prevention Trials: Focus on strategies to prevent the development or recurrence of urological diseases, including studies on lifestyle modifications, vaccinations, and early detection.
- Andrology Trials: Investigate treatments for male reproductive health issues, such as erectile dysfunction, male infertility, and testosterone replacement therapy.
Endpoints:
- Common endpoints in urology trials include improvements in symptoms (e.g., urinary frequency, pain), disease progression, quality of life, and overall survival.